PSEG's quarterly profit fell to US$376 million as utility costs rose. It maintained guidance and a US$24 billion to US$28 ...
Lightbridge held US$236.7 million at Sept. 30 as operating cash use increased and federal pilot-factory agreements remained ...
Bright Minds Biosciences says the FDA placed its planned Phase 2 BMB-101 seizure study on partial hold, citing mouse toxicity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results